BP002476-CHM-281: Recombinant Rat C-X-C motif chemokine 17 (CXCL17) Protein
Source: E. coli-derived.
Measured by its ability to induce VEGF expression in mouse endothelial cells. The ED50 for this effect is typically 1-5 ?g/ml.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP003501: Cynomolgus IL-8/CXCL8 Protein with the C-His Tag
Source: The recombinant Cynomolgus IL-8/CXCL8 Protein, (amino acids Ala23-Pro100) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus IL-8 protein with the C-His tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-IL-8 Antibody protein with the C-hFc tag with the EC50 of 13.0 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004782: Human IL-8/CXCL8 Protein with the C-His Tag
Source: The recombinant Human IL-8/CXCL8 Protein, (amino acids Ser28-Ser99) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human IL-8 protein with the C-His tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-IL-8 Antibody protein with the C-hFc tag with the EC50 of 12.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000271-C035: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The ED50 as determined by its chemotaxis of hCXCR-2 transfected mouse BaF/3 cells is less then 2 ng/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000271-C037: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The ED50 as determined by its chemotaxis of hCXCR-2 transfected mouse BaF/3 cells is less then 2 ng/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000271-CHM-231: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-327: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 25-150 ug/ml corresponding to a Specific Activity of 6,667-40,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-340: Recombinant Porcine Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The biological activity of IL8 was determined by the dose dependent mobilization of intracellular calcium (calcium flux) with human neutrophils and was found to be >1.0 ug/ml corresponding to a Specific Activity of 1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000271-CHM-349: Recombinant Human Interleukin-8 (IL-8) Protein, Pichia
Source: Pichia Pastoris-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration of 25 ug/ml corresponding to a Specific Activity of 40,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.